Bob Crutchfield
Operating Advisor @ Harbert Growth Partners
Birmingham, United States
Bob Crutchfield is a Series A investor at Harbert Growth Partners in Birmingham focused on Health Care and mHealth. Bob Crutchfield - Operating Advisor @ Harbert Growth Partners
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Bob Crutchfield invests in
Stages Bob Crutchfield invests in
Countries Bob Crutchfield invests in
Investment Focus
Industry
- Health Care 3 (100%)
- mHealth 1 (33%)
- Life Science 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 2 (67%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. | $16M / Series A / Jul 31, 2023 | |
|
|
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening. | $160M / Series B / Jul 24, 2019 | |
|
|
Founded by a tech-savvy nurse in 2007, RegisterPatient received venture funding and hired an executive management team with Healthcare IT expertise in 2013 to support a strong national rollout.With the addition of an expanded feature set and impressive mobile App, we thought the solution deserved its own name. IngagePatient is our term for thepremier patient engagement platform in the healthcare industry. Today, IngagePatient is a Florida-based company with corporate location in Nashville, Tennessee and customer support in Gainesville, Florida. | $4.1M / Series A / Oct 09, 2012 |
Co-Investors
About Harbert Growth Partners
Harbert Growth Partners is an emerging growth stage investor in tech and healthcare companies.
Harbert Growth Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bob Crutchfield
Operating Advisor
|
|||
|
Brandon Kusibab
Vice President of Investor Reporting
|
|||
|
Brian C. Carney
General Partner
|
|||
|
Chris Hartin
Vice President, Private Market Valuation and Analysis
|
|||
|
Jeffrey B. Liles
Chief Information Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bob Crutchfield invest in?
Bob Crutchfield invests primarily in Health Care, mHealth and Life Science startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bob Crutchfield last invest?
The most recent investment recorded for Bob Crutchfield closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!